Genmab A/S
CSE:GMAB

Watchlist Manager

Genmab A/S

CSE:GMAB

Watchlist

Dividends

Price: 1 534.5 DKK -1.35% Market Closed

Market Cap: 101B DKK

Have any thoughts about
Genmab A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 1534.5 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

GMAB Alert

Genmab A/S

1534.5

-21.0 (-1.35%)

52 Week Range	1 534.5 2 258
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Genmab A/S

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Genmab A/S.

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Summarize the latest earnings call
of Genmab A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genmab A/S.

Provide P/S
for Genmab A/S.

Provide P/E
for Genmab A/S.

Provide P/OCF
for Genmab A/S.

Provide P/FCFE
for Genmab A/S.

Provide P/B
for Genmab A/S.

Provide EV/S
for Genmab A/S.

Provide EV/GP
for Genmab A/S.

Provide EV/EBITDA
for Genmab A/S.

Provide EV/EBIT
for Genmab A/S.

Provide EV/OCF
for Genmab A/S.

Provide EV/FCFF
for Genmab A/S.

Provide EV/IC
for Genmab A/S.

Show me price targets
for Genmab A/S made by professional analysts.

What are the Revenue projections
for Genmab A/S?

How accurate were the past Revenue estimates
for Genmab A/S?

What are the Net Income projections
for Genmab A/S?

How accurate were the past Net Income estimates
for Genmab A/S?

What are the EPS projections
for Genmab A/S?

How accurate were the past EPS estimates
for Genmab A/S?

What are the EBIT projections
for Genmab A/S?

How accurate were the past EBIT estimates
for Genmab A/S?

Compare the revenue forecasts
for Genmab A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genmab A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genmab A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genmab A/S compared to its peers.

Compare the P/E ratios
of Genmab A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Genmab A/S with its peers.

Analyze the financial leverage
of Genmab A/S compared to its main competitors.

Show all profitability ratios
for Genmab A/S.

Provide ROE
for Genmab A/S.

Provide ROA
for Genmab A/S.

Provide ROIC
for Genmab A/S.

Provide ROCE
for Genmab A/S.

Provide Gross Margin
for Genmab A/S.

Provide Operating Margin
for Genmab A/S.

Provide Net Margin
for Genmab A/S.

Provide FCF Margin
for Genmab A/S.

Show all solvency ratios
for Genmab A/S.

Provide D/E Ratio
for Genmab A/S.

Provide D/A Ratio
for Genmab A/S.

Provide Interest Coverage Ratio
for Genmab A/S.

Provide Altman Z-Score Ratio
for Genmab A/S.

Provide Quick Ratio
for Genmab A/S.

Provide Current Ratio
for Genmab A/S.

Provide Cash Ratio
for Genmab A/S.

What is the historical Revenue growth
over the last 5 years for Genmab A/S?

What is the historical Net Income growth
over the last 5 years for Genmab A/S?

What is the current Free Cash Flow
of Genmab A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genmab A/S.

GMAB

Balance Sheet

Current Portion of Long-Term Debt

Genmab A/S
Current Portion of Long-Term Debt

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Genmab A/S
Current Portion of Long-Term Debt Peer Comparison

Comparables:

ZEAL

ASND

BAVA

FLUO

BIOPOR

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company		Current Portion of Long-Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Genmab A/S CSE:GMAB	Current Portion of Long-Term Debt kr94m	CAGR 3-Years 17%	CAGR 5-Years 25%	CAGR 10-Years N/A
	Zealand Pharma A/S CSE:ZEAL	Current Portion of Long-Term Debt kr29.9m	CAGR 3-Years 26%	CAGR 5-Years 55%	CAGR 10-Years N/A
	Ascendis Pharma A/S NASDAQ:ASND	Current Portion of Long-Term Debt €21.4m	CAGR 3-Years 45%	CAGR 5-Years 35%	CAGR 10-Years N/A
B	Bavarian Nordic A/S CSE:BAVA	Current Portion of Long-Term Debt kr41.9m	CAGR 3-Years -68%	CAGR 5-Years 21%	CAGR 10-Years 17%
F	Fluoguide AS STO:FLUO	Current Portion of Long-Term Debt kr10.2m	CAGR 3-Years 299%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bioporto A/S CSE:BIOPOR	Current Portion of Long-Term Debt kr2.2m	CAGR 3-Years 8%	CAGR 5-Years -5%	CAGR 10-Years 60%

What is Genmab A/S's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
94m DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Current Portion of Long-Term Debt amounts to 94m DKK.

What is Genmab A/S's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 5Y
25%

Over the last year, the Current Portion of Long-Term Debt growth was 15%. The average annual Current Portion of Long-Term Debt growth rates for Genmab A/S have been 17% over the past three years , 25% over the past five years .

Genmab A/S
CSE:GMAB

Genmab A/S
Current Portion of Long-Term Debt

Genmab A/S
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

See Also

What is Genmab A/S's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
94m DKK

What is Genmab A/S's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 5Y
25%

Company

Help

Tools

Stocks

Genmab A/S CSE:GMAB

Genmab A/S Current Portion of Long-Term Debt

Genmab A/S Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis Latest Figures & CAGR of Competitors

See Also

What is Genmab A/S's Current Portion of Long-Term Debt? Current Portion of Long-Term Debt 94m DKK

What is Genmab A/S's Current Portion of Long-Term Debt growth rate? Current Portion of Long-Term Debt CAGR 5Y 25%

Company

Help

Tools

Stocks

Genmab A/S
CSE:GMAB

Genmab A/S
Current Portion of Long-Term Debt

Genmab A/S
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

What is Genmab A/S's Current Portion of Long-Term Debt?

Current Portion of Long-Term Debt
94m DKK

What is Genmab A/S's Current Portion of Long-Term Debt growth rate?

Current Portion of Long-Term Debt CAGR 5Y
25%